FXR: a metabolic regulator and cell protector

被引:306
作者
Wang, Yan-Dong [1 ]
Chen, Wei-Dong [1 ]
Moore, David D. [2 ]
Huang, Wendong [1 ]
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Dept Gene Regulat & Drug Discovery, Duarte, CA 91010 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
FXR; bile acid; metabolism; liver regeneration; hepatocarcinogenesis;
D O I
10.1038/cr.2008.289
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily of ligand-activated transcription factors. As a metabolic regulator, FXR plays key roles in bile acid, cholesterol, lipid, and glucose metabolism. Therefore, FXR is a potential drug target for a number of metabolic disorders, especially those related to the metabolic syndrome. More recently, our group and others have extended the functions of FXR to more than metabolic regulation, which include anti-bacterial growth in intestine, liver regeneration, and hepatocarcinogenesis. These new findings suggest that FXR has much broader roles than previously thought, and also highlight FXR as a drug target for multiple diseases. This review summarizes the basic information of FXR but focuses on its new functions.
引用
收藏
页码:1087 / 1095
页数:9
相关论文
共 84 条
  • [1] Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor
    Ananthanarayanan, M
    Balasubramanian, N
    Makishima, M
    Mangelsdorf, DJ
    Suchy, FJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) : 28857 - 28865
  • [2] Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling
    Anisfeld, AM
    Kast-Woelbern, HR
    Lee, H
    Zhang, YQ
    Lee, FY
    Edwards, PA
    [J]. JOURNAL OF LIPID RESEARCH, 2005, 46 (03) : 458 - 468
  • [3] Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor
    Anisfeld, AM
    Kast-Woelbern, HR
    Meyer, ME
    Jones, SA
    Zhang, YQ
    Williams, KJ
    Willson, T
    Edwards, PA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) : 20420 - 20428
  • [4] Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice
    Barone, M
    Maiorano, E
    Ladisa, R
    Cuomo, R
    Pece, A
    Berloco, P
    Caruso, ML
    Valentini, AM
    Iolascon, A
    Francavilla, A
    Di Leo, A
    Ierardi, E
    [J]. HEPATOLOGY, 2003, 37 (04) : 880 - 886
  • [5] Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4
  • [6] BIANCHI L, 1993, EUR J PEDIATR, V152, pS63
  • [7] Expression and activation of the farnesoid X receptor in the vasculature
    Bishop-Bailey, D
    Walsh, DT
    Warner, TD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (10) : 3668 - 3673
  • [8] The farnesoid X receptor FXRα/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution
    Cai, Shi-Ying
    Xiong, Liangshi
    Wray, Charles G.
    Ballatori, Nazzareno
    Boyer, James L.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2007, 293 (03) : R1400 - R1409
  • [9] The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
    Cariou, B
    van Harmelen, K
    Duran-Sandoval, D
    van Dijk, TH
    Grefhorst, A
    Abdelkarim, M
    Caron, S
    Torpier, G
    Fruchart, JC
    Gonzalez, FJ
    Kuipers, F
    Staels, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (16) : 11039 - 11049
  • [10] FXR: a promising target for the metabolic syndrome?
    Cariou, Bertrand
    Staels, Bart
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2007, 28 (05) : 236 - 243